Related Experiment Video
Updated: May 11, 2025

04:23
A Treatment Package without Escape Extinction to Address Food Selectivity
Published on: August 21, 2015
11.4K
Screening for Avoidant/Restrictive Food Intake Disorder Symptoms Among Autistic Adults: Measurement Invariance With a
Courtney E Breiner1, Goldie A McQuaid2, Gregory L Wallace3
1New York State Psychiatric Institute, Columbia University Irving Medical Center, New York, New York, USA.
Summary
Avoidant/restrictive food intake disorder (ARFID) is more common in autistic adults. The Nine-Item ARFID Screen (NIAS) is a valid tool for identifying ARFID symptoms in this population, aiding diagnosis and treatment.
Area of Science:
- Psychiatry and Psychology
- Neurodevelopmental Disorders
- Eating Disorders
Background:
- Avoidant/restrictive food intake disorder (ARFID) is increasingly recognized in autistic individuals.
- ARFID symptoms in autistic people may be misattributed to autistic traits or co-occurring gastrointestinal issues, leading to underdiagnosis.
- Validating ARFID screening tools is crucial for accurate assessment and treatment monitoring in autistic populations.
Purpose of the Study:
- To evaluate the measurement invariance of the Nine-Item ARFID Screen (NIAS) in autistic adults compared to a general sample.
- To determine if the NIAS is a valid instrument for assessing ARFID symptomatology in autistic adults.
Main Methods:
- Multigroup confirmatory factor analysis was employed to assess the NIAS factor structure, loadings, and intercepts.
- Two samples were compared: autistic adults (n=248) and a general population sample (n=398).
Main Results:
- The NIAS demonstrated strong measurement invariance (configural, metric, scalar) across both samples.
- Autistic adults reported significantly higher scores on all three NIAS subscales: selective eating, appetite impairment, and fear-driven avoidance.
- Effect sizes for higher ARFID symptomatology in autistic adults ranged from d=0.27 to d=0.54.
Conclusions:
- The NIAS is a valid and reliable measure for assessing ARFID symptoms in autistic adults.
- Autistic adults exhibit elevated ARFID symptomatology across selective eating, appetite impairment, and fear-based avoidance.
- Further research is needed to confirm the efficacy of existing ARFID treatments for autistic adults or to adapt them.

